{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:33:05Z","timestamp":1784860385740,"version":"3.55.0"},"reference-count":52,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n \n Amnestic mild cognitive impairment (aMCI) represents a transitional stage between normal aging and Alzheimer disease (AD), where early intervention is critical for preserving cognition and delaying or preventing progression to dementia. Due to the limited availability of curative pharmacological treatments, there is growing interest in traditional and indigenous medicinal interventions, such as\n Bacopa monnieri<\/jats:italic>\n (Linn.) or Brahmi, a widely used Ayurvedic nootropic herb.\n Bacopa<\/jats:italic>\n consumption is known to enhance cognitive performance in healthy individuals and is associated with alterations in pathways related to branched-chain and aromatic amino acid biosynthesis. These pathways have been implicated in MCI due to AD pathophysiology. Hence, the efficacy of\n Bacopa<\/jats:italic>\n in aMCI and the mediating metabolic changes need to be systematically evaluated through clinical trials.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n The aim of this study is to assess the effects of\n B. monnieri<\/jats:italic>\n on cognitive function and plasma metabolites in individuals with aMCI (early or prodromal AD).\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This study will employ a double-blind, randomized, placebo-controlled trial design, with 76 participants (38 per group) of aMCI diagnosed using the clinical National Institute on Aging\u2013Alzheimer\u2019s Association 2011 criteria in a tertiary care setting in India. Participants will receive either\n B. monnieri<\/jats:italic>\n (Linn.) (300 mg standardized plant extract) or a matched placebo daily for 12 weeks. Comprehensive cognitive assessments (0, 12, and 24 wk) and untargeted plasma metabolomic profiling (0 and 12 wk) will be conducted to evaluate both cognitive changes and alterations in plasma metabolites. MetaboAnalyst 6.0 (with integrated features like Kyoto Encyclopedia of Genes and Genomes and the Human Metabolome Database) will be used for a comprehensive statistical and functional analysis pertaining to the metabolomics. The primary outcome will be a change in the composite\n z<\/jats:italic>\n score of memory between the 2 groups at 12 weeks. The secondary outcomes will include alterations in metabolites and pathways, and adverse events at 12 weeks, and cognitive performance at 12 and 24 weeks.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study was funded in October 2023, and the first participant was enrolled in April 2024. As of November 2025, a total of 60 participants have been recruited, with a mean (SD) age of 62.2 (8.1) years. The cohort predominantly comprises men (53\/60, 88.3%), individuals with at least a high school education (47\/60, 78.3%), and participants at elevated risk for cognitive decline. Specifically, 39 of 60 participants (65%) have diabetes, 29 (48.3%) have hypertension, and 13 (21%) report a positive family history of dementia. Data collection will conclude in June 2026, after which data analysis will begin and be completed by September 2026, with primary findings targeted for publication in spring 2027.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n This protocol investigates the efficacy of\n B. monnieri<\/jats:italic>\n (Linn.) in improving cognitive function and altering the blood metabolites in patients with aMCI. If effective, this intervention could provide an accessible and cost-effective approach to manage early AD in resource-limited settings.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/82891","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:51:56Z","timestamp":1772056316000},"page":"e82891-e82891","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9870-2568","authenticated-orcid":false,"given":"Abhilasha","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8187-2210","authenticated-orcid":false,"given":"Anjali","family":"Anjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-6794","authenticated-orcid":false,"given":"Hina","family":"Narzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-9624","authenticated-orcid":false,"given":"Yashwant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-3499","authenticated-orcid":false,"given":"Hanuman Prasad","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1992-389X","authenticated-orcid":false,"given":"Aditi","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-0915","authenticated-orcid":false,"given":"Nilima","family":"Nilima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-7252","authenticated-orcid":false,"given":"Roopa","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-8882","authenticated-orcid":false,"given":"Mamta","family":"Bhushan Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3654-8137","authenticated-orcid":false,"given":"Venugopalan Y","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-3202","authenticated-orcid":false,"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-5463","authenticated-orcid":false,"given":"Gautam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-6569","authenticated-orcid":false,"given":"Anu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"4","key":"R1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ncl.2024.05.007","article-title":"Mild cognitive impairment: quantifying a qualitative disorder","volume":"42","author":"Duff","journal-title":"Neurol Clin"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297220","article-title":"Prevalence of DSM-5 mild and major neurocognitive disorder in India: results from the LASI-DAD","volume":"19","author":"Gross","journal-title":"PLoS ONE"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1227112","article-title":"Evidence from a meta-analysis and systematic review reveals the global prevalence of mild cognitive impairment","volume":"15","author":"Song","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jnnp.2005.085332","article-title":"Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer\u2019s Disease","volume":"77","author":"Portet","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00052","article-title":"The differentiation of amnestic type MCI from the non\u2011amnestic types by structural MRI","volume":"8","author":"Csukly","journal-title":"Front Aging Neurosci"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/2052142","article-title":"Advancements and challenges in antiamyloid therapy for Alzheimer\u2019s disease: a comprehensive review","volume":"2024","author":"Beshir","journal-title":"Int J Alzheimers Dis"},{"issue":"4","key":"R7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.25259\/JNRP_356_2023","article-title":"Guidelines for pharmacotherapy in Alzheimer\u2019s disease \u2013 a primer on FDA\u2011approved drugs","volume":"14","author":"Varadharajan","journal-title":"J Neurosci Rural Pract"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis","volume":"213","author":"Zhang","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000475900","article-title":"Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer\u2019s disease","volume":"24","author":"Chaudhari","journal-title":"Ann Neurosci"},{"issue":"12","key":"R10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0973-7847.99949","article-title":"Nootropic herbs (Medhya Rasayana) in Ayurveda: an update","volume":"6","author":"Kulkarni","journal-title":"Pharmacogn Rev"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jep.2009.09.056","article-title":"Cognitive enhancement and neuroprotective effects of in Alzheimer\u2019s disease model","volume":"127","author":"Uabundit","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"R12","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s11064-013-1129-6","article-title":"ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems","volume":"38","author":"Le","journal-title":"Neurochem Res"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/254303","article-title":"A special extract of (CDRI\u201108) restores learning and memory by upregulating expression of the NMDA receptor subunit GluN2B in the brain of scopolamine\u2011induced amnesic mice","volume":"2015","author":"Rai","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"AF05","DOI":"10.7860\/JCDR\/2015\/10199.5423","article-title":"Effect of on cold stress induced neurodegeneration in hippocampus of wistar rats: a histomorphometric study","volume":"9","author":"Kumar","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ptr.4685","article-title":"increases cerebral blood flow in rat independent of blood pressure","volume":"27","author":"Kamkaew","journal-title":"Phytother Res"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/837012","article-title":"(CDRI\u201108) upregulates the expression of neuronal and glial plasticity markers in the brain of scopolamine induced amnesic mice","volume":"2015","author":"Konar","journal-title":"Evid Based Complement Alternat Med"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/615384","article-title":"as an antioxidant therapy to reduce oxidative stress in the aging brain","volume":"2015","author":"Simpson","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.etap.2008.08.007","article-title":"modulates antioxidant responses in brain and kidney of diabetic rats","volume":"27","author":"Kapoor","journal-title":"Environ Toxicol Pharmacol"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ptr.1061","article-title":"Free radical scavenging capacity and protective effect of L. on DNA damage","volume":"17","author":"Russo","journal-title":"Phytother Res"},{"issue":"11","key":"R20","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.13040\/IJPSR.0975-8232.3(11).4276-80","article-title":"Evaluation of the anti-amyloidogenic potential of nootropic herbal extracts in vitro","volume":"3","author":"Mathew","journal-title":"Int J Pharm Sci Res"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/jad-2006-9303","article-title":"extract reduces amyloid levels in PSAPP mice","volume":"9","author":"Holcomb","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jep.2008.07.039","article-title":"Neuroprotective effect of on beta-amyloid-induced cell death in primary cortical culture","volume":"120","author":"Limpeanchob","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jep.2013.11.008","article-title":"Meta-analysis of randomized controlled trials on cognitive effects of extract","volume":"151","author":"Kongkeaw","journal-title":"J Ethnopharmacol"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/606424","article-title":"Effects of 12-week consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers","volume":"2012","author":"Peth-Nui","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","DOI":"10.2196\/38542","article-title":"Use of in the treatment of dementia due to Alzheimer disease: systematic review of randomized controlled trials","volume":"11","author":"Basheer","journal-title":"Interact J Med Res"},{"issue":"10","key":"R26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26102944","article-title":"Characterization of metabolites in plasma, urine and feces of healthy participants after taking Brahmi essence for twelve weeks using LC\u2011ESI\u2011QTOF\u2011MS metabolomic approach","volume":"26","author":"Minale","journal-title":"Molecules"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00756","article-title":"Metabolomics and lipidomics study on serum metabolite signatures in Alzheimer\u2019s disease and mild cognitive impairment","volume":"22","author":"Mai","journal-title":"Neurotherapeutics"},{"issue":"6","key":"R28","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.14336\/AD.2020.0217","article-title":"Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer\u2019s disease","volume":"11","author":"Shao","journal-title":"Aging Dis"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12064","article-title":"Untargeted metabolomics reveal dysregulations in sugar, methionine, and tyrosine pathways in the prodromal state of AD","volume":"12","author":"Hajjar","journal-title":"Alzheimers Dement (Amst)"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01223","article-title":"The differences of serum metabolites between patients with early-stage Alzheimer's disease and mild cognitive impairment","volume":"10","author":"Weng","journal-title":"Front Neurol"},{"issue":"10","key":"R31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100949","article-title":"Multi\u2011omics, an integrated approach to identify novel blood biomarkers of Alzheimer\u2019s disease","volume":"12","author":"Fran\u00e7ois","journal-title":"Metabolites"},{"issue":"4","key":"R32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/JAD-200305","article-title":"A community\u2011based study identifying metabolic biomarkers of mild cognitive impairment and Alzheimer\u2019s disease using artificial intelligence and machine learning","volume":"78","author":"Yilmaz","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"R33","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf410","article-title":"Comprehensive metabolomics profiling reveals novel biomarkers and pathways for early detection of Alzheimer\u2019s disease","volume":"7","author":"Tiwari","journal-title":"Brain Commun"},{"issue":"3","key":"R34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","journal-title":"Alzheimers Dement"},{"issue":"4","key":"R35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000512393","article-title":"Validation of Indian Council of Medical Research Neurocognitive Tool Box in diagnosis of mild cognitive impairment in India: lessons from a harmonization process in a linguistically diverse society","volume":"49","author":"Menon","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"R36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1590\/S1980-57642014DN83000007","article-title":"Demographic effects on neuropsychological functions in older Indians","volume":"8","author":"Tripathi","journal-title":"Dement Neuropsychol"},{"key":"R37","unstructured":"Understanding alcohol drinking patterns. National Institute on Alcohol Abuse and Alcoholism. URL: https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohol-drinking-patterns [Accessed 27-01-2026]"},{"issue":"5","key":"R38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/arclin\/acaa013","article-title":"Dementia diagnosis in seven languages: the Addenbrooke\u2019s Cognitive Examination\u2011III in India","volume":"35","author":"Mekala","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"R39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1017\/s1041610205001547","article-title":"Instrumental activities of daily living scale for dementia screening in elderly people","volume":"17","author":"Mathuranath","journal-title":"Int Psychogeriatr"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S244707","article-title":"Hindi version of Addenbrooke\u2019s Cognitive Examination III: distinguishing cognitive impairment among older Indians at the lower cut\u2011offs","volume":"15","author":"Bajpai","journal-title":"Clin Interv Aging"},{"issue":"15","key":"R41","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1021\/acs.analchem.7b00925","article-title":"Development of a liquid chromatography\u2011high resolution mass spectrometry metabolomics method with high specificity for metabolite identification using all ion fragmentation acquisition","volume":"89","author":"Naz","journal-title":"Anal Chem"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68796-4","article-title":"Metabolomic analysis of primary human skeletal muscle cells during myogenic progression","volume":"10","author":"Kumar","journal-title":"Sci Rep"},{"issue":"7","key":"R43","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70257","article-title":"Interpreting Addenbrooke\u2019s Cognitive Examination-III scores in dementia: performance distributions and clinically meaningful change","volume":"32","author":"Carrick","journal-title":"Eur J Neurol"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.638109","article-title":"The neurocognitive effects of and cognitive training on markers of brain microstructure in healthy older adults","volume":"13","author":"McPhee","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"R45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.14283\/jpad.2016.10","article-title":"Short\u2011term impact of a combined nutraceutical on cognitive function, perceived stress and depression in young elderly with cognitive impairment: a pilot, double\u2011blind, randomized clinical trial","volume":"4","author":"Cicero","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"R46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/0019-5545.31555","article-title":"Randomized controlled trial of standardized extract in age-associated memory impairment","volume":"48","author":"Raghav","journal-title":"Indian J Psychiatry"},{"issue":"2","key":"R47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0893-133X(01)00419-5","article-title":"Chronic effects of Brahmi () on human memory","volume":"27","author":"Roodenrys","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"R48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00213-013-2978-z","article-title":"Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi () in healthy adults","volume":"227","author":"Sathyanarayanan","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"R49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.phymed.2007.03.010","article-title":"Safety evaluation of BacoMind in healthy volunteers: a phase I study","volume":"14","author":"Pravina","journal-title":"Phytomedicine"},{"issue":"12","key":"R50","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/ptr.2537","article-title":"Examining the nootropic effects of a special extract of on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial","volume":"22","author":"Stough","journal-title":"Phytother Res"},{"issue":"6","key":"R51","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/aian.AIAN_610_19","article-title":"Efficacy of (Brahmi) and donepezil in Alzheimer\u2019s disease and mild cognitive impairment: a randomized double\u2011blind parallel phase 2b study","volume":"23","author":"Prabhakar","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"R52","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040393","article-title":"Investigating the neuroprotective and cognitive\u2011enhancing effects of : a systematic review focused on inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis","volume":"13","author":"Valotto Neto","journal-title":"Antioxidants (Basel)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e82891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:16:59Z","timestamp":1782843419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e82891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2196\/82891","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"v15i4e82891"}}